-
1
-
-
84894471109
-
In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii
-
W. Ni, J. Cui, B. Liang, Y. Cai, N. Bai, X. Cai, and et al. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii J Antibiot (Tokyo) 66 2013 705 708
-
(2013)
J Antibiot (Tokyo)
, vol.66
, pp. 705-708
-
-
Ni, W.1
Cui, J.2
Liang, B.3
Cai, Y.4
Bai, N.5
Cai, X.6
-
2
-
-
34948861645
-
Global challenge of multidrug-resistant Acinetobacter baumannii
-
F. Perez, A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather, and R.A. Bonomo Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 3471 3484
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 3471-3484
-
-
Perez, F.1
Hujer, A.M.2
Hujer, K.M.3
Decker, B.K.4
Rather, P.N.5
Bonomo, R.A.6
-
4
-
-
84925267677
-
Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial
-
S.C. Kehl, and M.J. Dowzicky Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial J Clin Microbiol 53 2015 1286 1293
-
(2015)
J Clin Microbiol
, vol.53
, pp. 1286-1293
-
-
Kehl, S.C.1
Dowzicky, M.J.2
-
5
-
-
76249124162
-
Off-label use of antibiotics in hospitalized patients: focus on tigecycline
-
D. Curcio Off-label use of antibiotics in hospitalized patients: focus on tigecycline J Antimicrob Chemother 64 2009 1344 1346
-
(2009)
J Antimicrob Chemother
, vol.64
, pp. 1344-1346
-
-
Curcio, D.1
-
6
-
-
54349085650
-
Indications of a new antibiotic in clinical practice: results of the Tigecycline Initial Use Registry
-
D. Curcio, F. Fernández, A. Cané, L. Barcelona, and D. Stamboulian Indications of a new antibiotic in clinical practice: results of the Tigecycline Initial Use Registry Braz J Infect Dis 12 2008 198 201
-
(2008)
Braz J Infect Dis
, vol.12
, pp. 198-201
-
-
Curcio, D.1
Fernández, F.2
Cané, A.3
Barcelona, L.4
Stamboulian, D.5
-
7
-
-
79952325057
-
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease
-
Y. Cai, R. Wang, B. Liang, N. Bai, and Y. Liu Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease Antimicrob Agents Chemother 55 2011 1162 1172
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 1162-1172
-
-
Cai, Y.1
Wang, R.2
Liang, B.3
Bai, N.4
Liu, Y.5
-
8
-
-
80051692552
-
Efficacy and safety of tigecycline: a systematic review and meta-analysis
-
D. Yahav, A. Lador, M. Paul, and L. Leibovici Efficacy and safety of tigecycline: a systematic review and meta-analysis J Antimicrob Chemother 66 2011 1963 1971
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 1963-1971
-
-
Yahav, D.1
Lador, A.2
Paul, M.3
Leibovici, L.4
-
9
-
-
82455187892
-
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
-
E. Tasina, A.B. Haidich, S. Kokkali, and M. Arvanitidou Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis Lancet Infect Dis 11 2011 834 844
-
(2011)
Lancet Infect Dis
, vol.11
, pp. 834-844
-
-
Tasina, E.1
Haidich, A.B.2
Kokkali, S.3
Arvanitidou, M.4
-
10
-
-
84941208313
-
Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
-
F. Shen, Q. Han, D. Xie, M. Fang, H. Zeng, and Y. Deng Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs Int J Infect Dis 39 2015 25 33
-
(2015)
Int J Infect Dis
, vol.39
, pp. 25-33
-
-
Shen, F.1
Han, Q.2
Xie, D.3
Fang, M.4
Zeng, H.5
Deng, Y.6
-
11
-
-
13644257725
-
-
accessed 22.09.15
-
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp [accessed 22.09.15].
-
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analyses
-
-
Wells, G.A.1
Shea, B.2
O'Connell, D.3
Peterson, J.4
Welch, V.5
Losos, M.6
-
12
-
-
21544449115
-
Estimating the mean and variance from the median, range, and the size of a sample
-
S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
-
(2005)
BMC Med Res Methodol
, vol.5
, pp. 13
-
-
Hozo, S.P.1
Djulbegovic, B.2
Hozo, I.3
-
14
-
-
84882585192
-
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
-
Y.T. Lee, S.M. Tsao, and P.R. Hsueh Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections Eur J Clin Microbiol Infect Dis 32 2013 1211 1220
-
(2013)
Eur J Clin Microbiol Infect Dis
, vol.32
, pp. 1211-1220
-
-
Lee, Y.T.1
Tsao, S.M.2
Hsueh, P.R.3
-
16
-
-
84894610175
-
Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis
-
Y.C. Chuang, C.Y. Cheng, W.H. Sheng, H.Y. Sun, J.T. Wang, Y.C. Chen, and et al. Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis BMC Infect Dis 14 2014 102
-
(2014)
BMC Infect Dis
, vol.14
, pp. 102
-
-
Chuang, Y.C.1
Cheng, C.Y.2
Sheng, W.H.3
Sun, H.Y.4
Wang, J.T.5
Chen, Y.C.6
-
17
-
-
84898007596
-
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
-
T. Khawcharoenporn, N. Pruetpongpun, P. Tiamsak, S. Rutchanawech, L.M. Mundy, and A. Apisarnthanarak Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia Int J Antimicrob Agents 43 2014 378 382
-
(2014)
Int J Antimicrob Agents
, vol.43
, pp. 378-382
-
-
Khawcharoenporn, T.1
Pruetpongpun, N.2
Tiamsak, P.3
Rutchanawech, S.4
Mundy, L.M.5
Apisarnthanarak, A.6
-
18
-
-
84896944078
-
Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii
-
S.H. Kwon, H.L. Ahn, O.Y. Han, and H.O. La Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii Biol Pharm Bull 37 2014 340 346
-
(2014)
Biol Pharm Bull
, vol.37
, pp. 340-346
-
-
Kwon, S.H.1
Ahn, H.L.2
Han, O.Y.3
La, H.O.4
-
19
-
-
84942505201
-
Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study
-
A. Chaari, T. Pham, B. Mnif, K. Chtara, F. Medhioub, N. Baccouche, and et al. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study Intensive Care Med 41 2015 2018 2019
-
(2015)
Intensive Care Med
, vol.41
, pp. 2018-2019
-
-
Chaari, A.1
Pham, T.2
Mnif, B.3
Chtara, K.4
Medhioub, F.5
Baccouche, N.6
-
20
-
-
84937578574
-
Excess mortality associated with colistin-tigecycline compared with colistin-carbapenem combination therapy for extensively drug-resistant Acinetobacter baumannii bacteremia: a multicenter prospective observational study
-
A. Cheng, Y.C. Chuang, H.Y. Sun, W.H. Sheng, C.J. Yang, C.H. Liao, and et al. Excess mortality associated with colistin-tigecycline compared with colistin-carbapenem combination therapy for extensively drug-resistant Acinetobacter baumannii bacteremia: a multicenter prospective observational study Crit Care Med 43 2015 1194 1204
-
(2015)
Crit Care Med
, vol.43
, pp. 1194-1204
-
-
Cheng, A.1
Chuang, Y.C.2
Sun, H.Y.3
Sheng, W.H.4
Yang, C.J.5
Liao, C.H.6
-
21
-
-
84940705768
-
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
-
Aug 14, Epub ahead of print
-
S.S. Jean, T.C. Hsieh, C.W. Hsu, W.S. Lee, K.J. Bai, and C. Lam Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests J Microbiol Immunol Infect 2015 10.1016/j.jmii.2015.06.009 [Aug 14, Epub ahead of print]
-
(2015)
J Microbiol Immunol Infect
-
-
Jean, S.S.1
Hsieh, T.C.2
Hsu, C.W.3
Lee, W.S.4
Bai, K.J.5
Lam, C.6
-
22
-
-
34250896679
-
Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
-
J.J. Schafer, D.A. Goff, K.B. Stevenson, and J.E. Mangino Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii Pharmacotherapy 27 2007 980 987
-
(2007)
Pharmacotherapy
, vol.27
, pp. 980-987
-
-
Schafer, J.J.1
Goff, D.A.2
Stevenson, K.B.3
Mangino, J.E.4
-
23
-
-
38849130825
-
Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline
-
K.B. Anthony, N.O. Fishman, D.R. Linkin, L.B. Gasink, P.H. Edelstein, and E. Lautenbach Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline Clin Infect Dis 46 2008 567 570
-
(2008)
Clin Infect Dis
, vol.46
, pp. 567-570
-
-
Anthony, K.B.1
Fishman, N.O.2
Linkin, D.R.3
Gasink, L.B.4
Edelstein, P.H.5
Lautenbach, E.6
-
24
-
-
50249156755
-
Tigecycline for the treatment of Acinetobacter infections: a case series
-
J.C. Gallagher, and H.M. Rouse Tigecycline for the treatment of Acinetobacter infections: a case series Ann Pharmacother 42 2008 1188 1194
-
(2008)
Ann Pharmacother
, vol.42
, pp. 1188-1194
-
-
Gallagher, J.C.1
Rouse, H.M.2
-
25
-
-
63049101658
-
Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline
-
D. Curcio, F. Fernández, J. Vergara, W. Vazquez, and C.M. Luna Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline J Chemother 21 2009 58 62
-
(2009)
J Chemother
, vol.21
, pp. 58-62
-
-
Curcio, D.1
Fernández, F.2
Vergara, J.3
Vazquez, W.4
Luna, C.M.5
-
26
-
-
62549153583
-
A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline
-
N.C. Gordon, and D.W. Wareham A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline J Antimicrob Chemother 63 2009 775 780
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 775-780
-
-
Gordon, N.C.1
Wareham, D.W.2
-
27
-
-
63349106277
-
Tigecycline in the treatment of infections from multi-drug resistant Gram-negative pathogens
-
G. Poulakou, F.V. Kontopidou, E. Paramythiotou, M. Kompoti, M. Katsiari, E. Mainas, and et al. Tigecycline in the treatment of infections from multi-drug resistant Gram-negative pathogens J Infect 58 2009 273 284
-
(2009)
J Infect
, vol.58
, pp. 273-284
-
-
Poulakou, G.1
Kontopidou, F.V.2
Paramythiotou, E.3
Kompoti, M.4
Katsiari, M.5
Mainas, E.6
-
28
-
-
77951555223
-
Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections
-
G. Metan, E. Alp, O. Yildiz, D. Percin, B. Aygen, and B. Sumerkan Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections J Chemother 22 2010 110 114
-
(2010)
J Chemother
, vol.22
, pp. 110-114
-
-
Metan, G.1
Alp, E.2
Yildiz, O.3
Percin, D.4
Aygen, B.5
Sumerkan, B.6
-
29
-
-
82655173952
-
Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy
-
R. Guner, I. Hasanoglu, S. Keske, A.K. Kalem, and M.A. Tasyaran Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy Infection 39 2011 515 518
-
(2011)
Infection
, vol.39
, pp. 515-518
-
-
Guner, R.1
Hasanoglu, I.2
Keske, S.3
Kalem, A.K.4
Tasyaran, M.A.5
-
30
-
-
79952248676
-
Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients
-
S.C. Kuo, F.D. Wang, C.P. Fung, L.Y. Chen, S.J. Chen, M.C. Chiang, and et al. Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients J Microbiol Immunol Infect 44 2011 45 51
-
(2011)
J Microbiol Immunol Infect
, vol.44
, pp. 45-51
-
-
Kuo, S.C.1
Wang, F.D.2
Fung, C.P.3
Chen, L.Y.4
Chen, S.J.5
Chiang, M.C.6
-
31
-
-
84864928200
-
Is tigecycline a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?
-
M.S. Tasbakan, H. Pullukcu, O.R. Sipahi, M.I. Tasbakan, S. Aydemir, and F. Bacakoglu Is tigecycline a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia? J Chemother 23 2011 345 349
-
(2011)
J Chemother
, vol.23
, pp. 345-349
-
-
Tasbakan, M.S.1
Pullukcu, H.2
Sipahi, O.R.3
Tasbakan, M.I.4
Aydemir, S.5
Bacakoglu, F.6
-
32
-
-
80054089411
-
The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
-
J.J. Ye, H.S. Lin, A.J. Kuo, H.S. Leu, P.C. Chiang, C.T. Huang, and et al. The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii J Infect 63 2011 351 361
-
(2011)
J Infect
, vol.63
, pp. 351-361
-
-
Ye, J.J.1
Lin, H.S.2
Kuo, A.J.3
Leu, H.S.4
Chiang, P.C.5
Huang, C.T.6
-
33
-
-
84869471805
-
Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp
-
S.Y. Moon, K.R. Peck, H.H. Chang, S.W. Kim, S.T. Heo, J.S. Son, and et al. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp Microb Drug Resist 18 2012 562 566
-
(2012)
Microb Drug Resist
, vol.18
, pp. 562-566
-
-
Moon, S.Y.1
Peck, K.R.2
Chang, H.H.3
Kim, S.W.4
Heo, S.T.5
Son, J.S.6
-
34
-
-
84864592249
-
Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection
-
J.A. Shin, Y.S. Chang, H.J. Kim, S.K. Kim, J. Chang, C.M. Ahn, and et al. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection Yonsei Med J 53 2012 974 984
-
(2012)
Yonsei Med J
, vol.53
, pp. 974-984
-
-
Shin, J.A.1
Chang, Y.S.2
Kim, H.J.3
Kim, S.K.4
Chang, J.5
Ahn, C.M.6
-
35
-
-
84878022695
-
Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital
-
V. Avkan-Oguz, N. Yapar, S. Alp-Cavus, K. Demir Onder, E. Aktas, Z. Gulay, and et al. Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital Int J Clin Pract 67 2013 505 511
-
(2013)
Int J Clin Pract
, vol.67
, pp. 505-511
-
-
Avkan-Oguz, V.1
Yapar, N.2
Alp-Cavus, S.3
Demir Onder, K.4
Aktas, E.5
Gulay, Z.6
-
36
-
-
84901590141
-
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
-
G. De Pascale, L. Montini, M. Pennisi, V. Bernini, R. Maviglia, G. Bello, and et al. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria Crit Care 18 2014 R90
-
(2014)
Crit Care
, vol.18
, pp. R90
-
-
De Pascale, G.1
Montini, L.2
Pennisi, M.3
Bernini, V.4
Maviglia, R.5
Bello, G.6
-
37
-
-
84937562905
-
Clinical evaluation of tigecycline in the treatment of nosocomial infection in a hospital in Taiwan
-
M.T. Wu, H.Y. Chen, T.Y. Ou, L.N. Kuo, K.J. Cheng, and W.S. Lee Clinical evaluation of tigecycline in the treatment of nosocomial infection in a hospital in Taiwan Int J Clin Pharmacol Ther 52 2014 1030 1036
-
(2014)
Int J Clin Pharmacol Ther
, vol.52
, pp. 1030-1036
-
-
Wu, M.T.1
Chen, H.Y.2
Ou, T.Y.3
Kuo, L.N.4
Cheng, K.J.5
Lee, W.S.6
-
38
-
-
84929648571
-
Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure
-
B.H. Liou, Y.T. Lee, S.C. Kuo, P.Y. Liu, and C.P. Fung Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure Antimicrob Agents Chemother 59 2015 3637 3640
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 3637-3640
-
-
Liou, B.H.1
Lee, Y.T.2
Kuo, S.C.3
Liu, P.Y.4
Fung, C.P.5
-
39
-
-
84856944445
-
What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression
-
D.F. Florescu, F. Qiu, M.A. McCartan, C. Mindru, P.D. Fey, and A.C. Kalil What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression Clin Infect Dis 54 2012 670 680
-
(2012)
Clin Infect Dis
, vol.54
, pp. 670-680
-
-
Florescu, D.F.1
Qiu, F.2
McCartan, M.A.3
Mindru, C.4
Fey, P.D.5
Kalil, A.C.6
-
40
-
-
17644389620
-
Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections
-
M.E. Falagas, and S.K. Kasiakou Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections Clin Infect Dis 40 2005 1333 1341
-
(2005)
Clin Infect Dis
, vol.40
, pp. 1333-1341
-
-
Falagas, M.E.1
Kasiakou, S.K.2
-
41
-
-
84925841586
-
Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
-
W. Ni, X. Cai, C. Wei, X. Di, J. Cui, R. Wang, and et al. Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis Braz J Infect Dis 19 2015 170 180
-
(2015)
Braz J Infect Dis
, vol.19
, pp. 170-180
-
-
Ni, W.1
Cai, X.2
Wei, C.3
Di, X.4
Cui, J.5
Wang, R.6
-
42
-
-
84902585467
-
Efficacy and safety of polymyxins for the treatment of Acinetobacter baumannii infection: a systematic review and meta-analysis
-
Q. Liu, W. Li, Y. Feng, and C. Tao Efficacy and safety of polymyxins for the treatment of Acinetobacter baumannii infection: a systematic review and meta-analysis PLOS ONE 9 2014 e98091
-
(2014)
PLOS ONE
, vol.9
-
-
Liu, Q.1
Li, W.2
Feng, Y.3
Tao, C.4
-
43
-
-
80054762740
-
Pharmacokinetic and pharmacodynamic evaluation of tigecycline
-
H. Giamarellou, and G. Poulakou Pharmacokinetic and pharmacodynamic evaluation of tigecycline Expert Opin Drug Metab Toxicol 7 2011 1459 1470
-
(2011)
Expert Opin Drug Metab Toxicol
, vol.7
, pp. 1459-1470
-
-
Giamarellou, H.1
Poulakou, G.2
-
44
-
-
19544371022
-
Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
-
J.E. Conte Jr., J.A. Golden, M.G. Kelly, and E. Zurlinden Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline Int J Antimicrob Agents 25 2005 523 529
-
(2005)
Int J Antimicrob Agents
, vol.25
, pp. 523-529
-
-
Conte, J.E.1
Golden, J.A.2
Kelly, M.G.3
Zurlinden, E.4
-
46
-
-
84911003547
-
Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review
-
P. Poulikakos, G.S. Tansarli, and M.E. Falagas Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review Eur J Clin Microbiol Infect Dis 33 2014 1675 1685
-
(2014)
Eur J Clin Microbiol Infect Dis
, vol.33
, pp. 1675-1685
-
-
Poulikakos, P.1
Tansarli, G.S.2
Falagas, M.E.3
-
47
-
-
84902539127
-
Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections
-
M.E. Falagas, K.Z. Vardakas, K.P. Tsiveriotis, N.A. Triarides, and G.S. Tansarli Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections Int J Antimicrob Agents 44 2014 1 7
-
(2014)
Int J Antimicrob Agents
, vol.44
, pp. 1-7
-
-
Falagas, M.E.1
Vardakas, K.Z.2
Tsiveriotis, K.P.3
Triarides, N.A.4
Tansarli, G.S.5
-
48
-
-
50149096410
-
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
-
N. Petrosillo, E. Ioannidou, and M.E. Falagas Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies Clin Microbiol Infect 14 2008 816 827
-
(2008)
Clin Microbiol Infect
, vol.14
, pp. 816-827
-
-
Petrosillo, N.1
Ioannidou, E.2
Falagas, M.E.3
-
49
-
-
79951880812
-
Can pharmacokinetic and pharmacodynamic principles be applied to the treatment of multidrug-resistant Acinetobacter?
-
T.W. Cooper, S.E. Pass, S.D. Brouse, and R.G. Hall Can pharmacokinetic and pharmacodynamic principles be applied to the treatment of multidrug-resistant Acinetobacter? Ann Pharmacother 45 2011 229 240
-
(2011)
Ann Pharmacother
, vol.45
, pp. 229-240
-
-
Cooper, T.W.1
Pass, S.E.2
Brouse, S.D.3
Hall, R.G.4
-
50
-
-
67349135277
-
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
-
O. Burkhardt, K. Rauch, V. Kaever, J. Hadem, J.T. Kielstein, and T. Welte Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint Int J Antimicrob Agents 34 2009 101 102
-
(2009)
Int J Antimicrob Agents
, vol.34
, pp. 101-102
-
-
Burkhardt, O.1
Rauch, K.2
Kaever, V.3
Hadem, J.4
Kielstein, J.T.5
Welte, T.6
-
51
-
-
66149085768
-
Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis
-
B.A. Cunha Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis J Clin Microbiol 47 2009 1613
-
(2009)
J Clin Microbiol
, vol.47
, pp. 1613
-
-
Cunha, B.A.1
-
52
-
-
84875180696
-
Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia
-
J. Ramirez, N. Dartois, H. Gandjini, J.L. Yan, J. Korth-Bradley, and P.C. McGovern Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia Antimicrob Agents Chemother 57 2013 1756 1762
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 1756-1762
-
-
Ramirez, J.1
Dartois, N.2
Gandjini, H.3
Yan, J.L.4
Korth-Bradley, J.5
McGovern, P.C.6
|